Bill Gates invests $50m in Dementia Discovery Fund

13 November 2017 – Bill Gates has invested USD $50 million in the Dementia Discovery Fund. Alzheimer's Disease International (ADI) applauds the landmark contribution, that it is hoped will aid the development of new treatment options for 50 million people affected by dementia globally.

Dementia will become a trillion-dollar disease in 2018 and is the only major chronic disease area that does not have a cure or effective treatment. Gates acknowledged the financial and human impact of the disease, urging that more research was needed to better understand the disease, that innovation was needed to involve more people in clinical trials and that data can play a critical role to shape the future; “This is a frontier where we can dramatically improve human life.People should be able to enjoy their later years – and we need a breakthrough in Alzheimer’s to fulfill that. I’m excited to join the fight and can’t wait to see what happens next.”

Paola Barbarino, CEO of ADI said, “The entry of such a high profile private investor into the dementia market is welcome news. There is still so little we know about this devastating disease and such a significant and timely contribution towards finding a solution is greatly welcomed.

The areas identified by the fund, and innovation in particular, are all of great interest to ADI, our members and partners. We hope that this announcement will reinvigorate the investment environment around dementia and prompt more investors to pool resources.”

The Fund provides a platform for collaboration between civil society, industry and government to develop novel and early stage approaches to identifying potential treatments. ADI welcomes the  investment by Gates, that supports a new era of collaboration and innovation to improve the lives of people with dementia, their care partners and their families.

Where next?